Raymond James Financial Inc Tekla Life Sciences Investors Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Raymond James Financial Inc holds 238,470 shares of HQL stock, worth $3.42 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
238,470Holding current value
$3.42 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HQL
# of Institutions
77Shares Held
9.87MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$49.2 Million1.1% of portfolio
-
Penserra Capital Management LLC Orinda, CA776KShares$11.1 Million0.25% of portfolio
-
Morgan Stanley New York, NY490KShares$7.03 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY469KShares$6.72 Million0.23% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN417KShares$5.98 Million0.14% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...